Prognostic factors in children with Hodgkin disease.
Celkan
Tiraje
T
Yildiz
Inci
I
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D006689:Hodgkin Disease / Q000401:mortality* / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008466:Mechlorethamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D011878:Radiotherapy; D016019:Survival Analysis; D014750:Vincristine / Q000627:therapeutic use
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone